In July, “Süddeutsche Zeitung”, NDR and WDR reported on the lucrative business with cancer infusions. Since then, the pharmacist Robert Herold, who gave deep insights into what happened, has been put under pressure by his guild.
Pharmacist Robert Herold told Robert Herold in July of this year that he was afraid of being seen as a “fouler”. Süddeutscher Zeitung, NDR and WDR formulated. He probably suspected that his industry would not be happy about what he wanted to make public: how cheaply pharmacists like him can buy many active ingredients for cancer infusions, so-called cytostatics and monoclonal antibodies – and how much more money the health insurance companies reimburse them. For some active ingredients, you can earn 1,000 euros or more on the side with a single infusion bag that you prepare for each patient in the laboratory. Although they already receive a production fee of 100 euros from the health insurance companies, which is actually supposed to cover the costs of preparation and the profit.